Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph 1 Safety and Tolerability of XmAb®18087 w/ Adv Neuroendocrine and Gastrointestinal stromal Tumor

Protocol: OSU-17296

Full Title

A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®18087 in Subjects with Advanced Neuroendocrine and Gastrointestinal stromal Tumor

Endocrine Cancers Gastrointestinal Carcinoid Tumors Neuroendocrine Cancer